{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T19:16:13Z","timestamp":1757618173819,"version":"3.44.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T00:00:00Z","timestamp":1748908800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Vet Res Commun"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1007\/s11259-025-10782-0","type":"journal-article","created":{"date-parts":[[2025,6,3]],"date-time":"2025-06-03T04:14:43Z","timestamp":1748924083000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of high-dose alacepril on the renin-angiotensin-aldosterone system and autonomic nervous system function in healthy dogs"],"prefix":"10.1007","volume":"49","author":[{"given":"Toshiharu","family":"Fukayama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisako","family":"Kyojima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mao","family":"Koike","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Tadakuma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuma","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seijirow","family":"Goya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,3]]},"reference":[{"key":"10782_CR1","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1111\/jvim.15331","volume":"32","author":"MJ Acierno","year":"2018","unstructured":"Acierno MJ, Brown S, Coleman AE et al (2018) ACVIM consensus statement: guidelines for the identification, evaluation, and management of systemic hypertension in dogs and cats. J Vet Intern Med 32:1803\u20131822. https:\/\/doi.org\/10.1111\/jvim.15331","journal-title":"J Vet Intern Med"},{"key":"10782_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1760-2734(06)70025-X","volume":"1","author":"BENCH (BENazepril in Canine Heart disease) Study Group","year":"1999","unstructured":"BENCH (BENazepril in Canine Heart disease) Study Group (1999) The effect of Benazepril on survival times and clinical signs of dogs with congestive heart failure: results of a multicenter, prospective, randomized, double-blinded, placebo-controlled, long-term clinical trial. J Vet Cardiol 1:7\u201318. https:\/\/doi.org\/10.1016\/S1760-2734(06)70025-X","journal-title":"J Vet Cardiol"},{"key":"10782_CR3","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/ncpneph0575","volume":"3","author":"AS Bomback","year":"2007","unstructured":"Bomback AS, Klemmer PJ (2007) The incidence and implications of aldosterone breakthrough. Nat Clin Pract Nephrol 3:486\u2013492. https:\/\/doi.org\/10.1038\/ncpneph0575","journal-title":"Nat Clin Pract Nephrol"},{"key":"10782_CR4","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1161\/hc0502.102962","volume":"105","author":"A Cataliotti","year":"2002","unstructured":"Cataliotti A, Boerrigter G, Chen HH et al (2002) Differential actions of vasopeptidase inhibition versus angiotensin-converting enzyme Inhibition on diuretic therapy in experimental congestive heart failure. Circulation 105:639\u2013644. https:\/\/doi.org\/10.1161\/hc0502.102962","journal-title":"Circulation"},{"key":"10782_CR5","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1097\/FJC.0b013e318135446c","volume":"50","author":"S Del Colle","year":"2007","unstructured":"Del Colle S, Morello F, Rabbia F et al (2007) Antihypertensive drugs and the sympathetic nervous system. J Cardiovasc Pharmacol 50:487\u2013496. https:\/\/doi.org\/10.1097\/FJC.0b013e318135446c","journal-title":"J Cardiovasc Pharmacol"},{"key":"10782_CR6","doi-asserted-by":"publisher","first-page":"1573","DOI":"10.2460\/javma.1998.213.11.1573","volume":"213","author":"SJ Ettinger","year":"1998","unstructured":"Ettinger SJ, Benitz AM, Ericsson GF et al (1998) Effects of enalapril maleate on survival of dogs with naturally acquired heart failure. The Long-Term Investigation of Veterinary Enalapril (LIVE) study group. J Am Vet Med Assoc 213:1573\u20131577","journal-title":"J Am Vet Med Assoc"},{"key":"10782_CR7","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.tvjl.2018.12.017","volume":"245","author":"S Goya","year":"2019","unstructured":"Goya S, Wada T, Shimada K, Hirao D, Tanaka R (2019) Effects of high-dose alacepril on left atrial pressure and central aortic pressure in awake dogs with mitral valve regurgitation. Vet J 245:7\u201311. https:\/\/doi.org\/10.1016\/j.tvjl.2018.12.017","journal-title":"Vet J"},{"key":"10782_CR8","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.2174\/1381612043382756","volume":"10","author":"G Grassi","year":"2004","unstructured":"Grassi G (2004) Sympathetic and baroreflex function in hypertension: implications for current and new drugs. Curr Pharm Des 10:3579\u20133589. https:\/\/doi.org\/10.2174\/1381612043382756","journal-title":"Curr Pharm Des"},{"key":"10782_CR9","doi-asserted-by":"publisher","first-page":"143","DOI":"10.3999\/jscpt.23.143","volume":"23","author":"T Haneno","year":"1992","unstructured":"Haneno T (1992) Norepinephrine release inhibitory effect from the peripheral sympathetic nerve ending by angiotensin converting enzyme inhibitor. Comparison of desacetylalacepril and captopril. Rinsho yakuri\/Jpn J Clin Pharmacol Ther 23:143\u2013144. https:\/\/doi.org\/10.3999\/jscpt.23.143","journal-title":"Rinsho yakuri\/Jpn J Clin Pharmacol Ther"},{"key":"10782_CR10","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.autneu.2018.01.002","volume":"210","author":"D Haspula","year":"2018","unstructured":"Haspula D, Clark MA (2018) Neuroinflammation and sympathetic overactivity: mechanisms and implications in hypertension. Auton Neurosci 210:10\u201317. https:\/\/doi.org\/10.1016\/j.autneu.2018.01.002","journal-title":"Auton Neurosci"},{"key":"10782_CR11","doi-asserted-by":"publisher","first-page":"1212","DOI":"10.1292\/jvms.17-0557","volume":"80","author":"Y Hori","year":"2018","unstructured":"Hori Y, Nakamura K, Kanno N et al (2018) Effects of the angiotensin-converting enzyme inhibitor alacepril in dogs with mitral valve disease. J Vet Med Sci 80:1212\u20131218. https:\/\/doi.org\/10.1292\/jvms.17-0557","journal-title":"J Vet Med Sci"},{"key":"10782_CR12","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1939-1676.2009.0455.x","volume":"24","author":"T Ishikawa","year":"2010","unstructured":"Ishikawa T, Tanaka R, Suzuki S et al (2010) The effect of angiotensin-converting enzyme inhibitors of left atrial pressure in dogs with mitral valve regurgitation. J Vet Intern Med 24:342\u2013347. https:\/\/doi.org\/10.1111\/j.1939-1676.2009.0455.x","journal-title":"J Vet Intern Med"},{"key":"10782_CR13","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1292\/jvms.10-0141","volume":"73","author":"T Ishikawa","year":"2011","unstructured":"Ishikawa T, Fukushima R, Suzuki S et al (2011) Echocardiographic estimation of left atrial pressure in beagle dogs with experimentally-induced mitral valve regurgitation. J Vet Med Sci 73:1015\u20131024. https:\/\/doi.org\/10.1292\/jvms.10-0141","journal-title":"J Vet Med Sci"},{"key":"10782_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.cvsm.2010.03.011","volume":"40","author":"HB Kellihan","year":"2010","unstructured":"Kellihan HB, Stepien RL (2010) Pulmonary hypertension in dogs: diagnosis and therapy. Vet Clin North Am Small Anim Pract 40:623\u2013641. https:\/\/doi.org\/10.1016\/j.cvsm.2010.03.011","journal-title":"Vet Clin North Am Small Anim Pract"},{"key":"10782_CR15","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1046\/j.1440-1681.2002.03779.x","volume":"29","author":"T Kinugawa","year":"2002","unstructured":"Kinugawa T, Osaki S, Kato M et al (2002) Effects of the angiotensin-converting enzyme inhibitor alacepril on exercise capacity and neurohormonal factors in patients with mild-to-moderate heart failure. Clin Exp Pharmacol Physiol 29:1060\u20131065. https:\/\/doi.org\/10.1046\/j.1440-1681.2002.03779.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10782_CR16","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3389\/fphys.2012.00335","volume":"3","author":"T Kishi","year":"2012","unstructured":"Kishi T, Hirooka Y (2012) Oxidative stress in the brain causes hypertension via sympathoexcitation. Front Physiol 3:335. https:\/\/doi.org\/10.3389\/fphys.2012.00335","journal-title":"Front Physiol"},{"key":"10782_CR17","doi-asserted-by":"publisher","first-page":"2357","DOI":"10.1161\/01.CIR.0000128695.49900.12","volume":"109","author":"T Kishi","year":"2004","unstructured":"Kishi T, Hirooka Y, Kimura Y et al (2004) Increased reactive oxygen species in rostral ventrolateral medulla contribute to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 109:2357\u20132362. https:\/\/doi.org\/10.1161\/01.CIR.0000128695.49900.12","journal-title":"Circulation"},{"key":"10782_CR18","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/jvp.12154","volume":"38","author":"AC Lantis","year":"2015","unstructured":"Lantis AC, Ames MK, Atkins CE et al (2015) Aldosterone breakthrough with benazepril in furosemide-activated renin-angiotensin-aldosterone system in normal dogs. J Vet Pharmacol Ther 38:65\u201373. https:\/\/doi.org\/10.1111\/jvp.12154","journal-title":"J Vet Pharmacol Ther"},{"key":"10782_CR19","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1002\/clc.4960130811","volume":"13","author":"M Malik","year":"1990","unstructured":"Malik M, Camm AJ (1990) Heart rate variability. Clin Cardiol 13:570\u2013576. https:\/\/doi.org\/10.1002\/clc.4960130811","journal-title":"Clin Cardiol"},{"key":"10782_CR20","doi-asserted-by":"publisher","first-page":"e17255","DOI":"10.1111\/jvim.17255","volume":"39","author":"E Manson","year":"2025","unstructured":"Manson E, Ward JL, Merodio M et al (2025) Dose-exposure-response of CARDALIS\u00ae (benazepril\/spironolactone) on the classical and alternative arms of the renin-angiotensin-aldosterone system in healthy dogs. J Vet Intern Med 39:e17255. https:\/\/doi.org\/10.1111\/jvim.17255","journal-title":"J Vet Intern Med"},{"key":"10782_CR21","first-page":"52","volume":"36","author":"K Matsumoto","year":"1986","unstructured":"Matsumoto K, Nambu K, Fujii T et al (1986) Metabolism of protein conjugate of desacetyl-alacepril and its effect on angiotensin converting enzyme in renal hypertensive rats. Arzneimittelforschung 36:52\u201354","journal-title":"Arzneimittelforschung"},{"key":"10782_CR22","first-page":"55","volume":"36","author":"Y Matsuno","year":"1986","unstructured":"Matsuno Y, Taira N, Fujitani B, Ito T, Kadokawa T (1986) General Pharmacology of the novel angiotensin converting enzyme inhibitor alacepril. 1st communication: effects on cardiovascular, visceral and renal functions and on blood. Arzneimittelforschung 36:55\u201362","journal-title":"Arzneimittelforschung"},{"key":"10782_CR23","doi-asserted-by":"publisher","first-page":"C82","DOI":"10.1152\/ajpcell.00287.2006","volume":"292","author":"PK Mehta","year":"2007","unstructured":"Mehta PK, Griendling KK (2007) Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system. Am J Physiol Cell Physiol 292:C82\u201397. https:\/\/doi.org\/10.1152\/ajpcell.00287.2006","journal-title":"Am J Physiol Cell Physiol"},{"key":"10782_CR24","first-page":"319","volume":"39","author":"H Minato","year":"1989","unstructured":"Minato H, Hosoki K, Hayashi K et al (1989) Antihypertensive mechanism of alacepril. Effects of its metabolites on the peripheral sympathetic nervous system. Arzneim Forsch 39:319\u2013324","journal-title":"Arzneim Forsch"},{"key":"10782_CR25","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1111\/j.1365-2885.2012.01406.x","volume":"36","author":"JP Mochel","year":"2013","unstructured":"Mochel JP, Peyrou M, Fink M et al (2013) Capturing the dynamics of systemic Renin-Angiotensin-Aldosterone System (RAAS) peptides heightens the understanding of the effect of benazepril in dogs. J Vet Pharmacol Ther 36:174\u2013180. https:\/\/doi.org\/10.1111\/j.1365-2885.2012.01406.x","journal-title":"J Vet Pharmacol Ther"},{"key":"10782_CR26","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1161\/HYPERTENSIONAHA.112.196782","volume":"60","author":"M Nautiyal","year":"2012","unstructured":"Nautiyal M, Shaltout HA, de Lima DC et al (2012) Central angiotensin-(1\u20137) improves vagal function independent of blood pressure in hypertensive (mRen2)27 rats. Hypertension 60:1257\u20131265. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.112.196782","journal-title":"Hypertension"},{"key":"10782_CR27","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1291\/hypres.31.29","volume":"31","author":"H Nonoguchi","year":"2008","unstructured":"Nonoguchi H, Kiyama S, Kitamura K et al (2008) Long-term plasma levels and dose modulation of alacepril in patients with chronic renal failure. Hypertens Res 31:29\u201336. https:\/\/doi.org\/10.1291\/hypres.31.29","journal-title":"Hypertens Res"},{"key":"10782_CR28","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11259-020-09774-z","volume":"44","author":"M Ogawa","year":"2020","unstructured":"Ogawa M, Ishizaka M, Akabane R et al (2020) Evaluation of the autonomic nervous system in a canine model of chronic embolic pulmonary hypertension. Vet Res Commun 44:73\u201381. https:\/\/doi.org\/10.1007\/s11259-020-09774-z","journal-title":"Vet Res Commun"},{"key":"10782_CR29","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1527-3466.1992.tb00238.x","volume":"10","author":"T Ogihara","year":"1992","unstructured":"Ogihara T, Tachi Y, Uno H (1992) Alacepril. Cardiovasc Drug Rev 10:88\u2013100. https:\/\/doi.org\/10.1111\/j.1527-3466.1992.tb00238.x","journal-title":"Cardiovasc Drug Rev"},{"key":"10782_CR30","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1152\/japplphysiol.00022.2011","volume":"111","author":"Y-J Peng","year":"2011","unstructured":"Peng Y-J, Raghuraman G, Khan SA, Kumar GK, Prabhakar NR (2011) Angiotensin II evokes sensory long-term facilitation of the carotid body via NADPH oxidase. J Appl Physiol 111:964\u2013970. https:\/\/doi.org\/10.1152\/japplphysiol.00022.2011","journal-title":"J Appl Physiol"},{"key":"10782_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1111\/j.1476-5381.1982.tb08752.x","volume":"75","author":"EK Potter","year":"1982","unstructured":"Potter EK (1982) Angiotensin inhibits action of vagus nerve at the heart. Br J Pharmacol 75:9\u201311. https:\/\/doi.org\/10.1111\/j.1476-5381.1982.tb08752.x","journal-title":"Br J Pharmacol"},{"key":"10782_CR32","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1161\/HYPERTENSIONAHA.111.181131","volume":"59","author":"R Ramchandra","year":"2012","unstructured":"Ramchandra R, Hood SG, Watson AMD et al (2012) Central angiotensin type 1 receptor blockade decreases cardiac but not renal sympathetic nerve activity in heart failure. Hypertension 59:634\u2013641. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.111.181131","journal-title":"Hypertension"},{"key":"10782_CR33","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/j.1476-5381.1993.tb13807.x","volume":"110","author":"M Rechtman","year":"1993","unstructured":"Rechtman M, Majewski H (1993) A facilitatory effect of anti-angiotensin drugs on vagal bradycardia in the pithed rat and guinea-pig. Br J Pharmacol 110:289\u2013296. https:\/\/doi.org\/10.1111\/j.1476-5381.1993.tb13807.x","journal-title":"Br J Pharmacol"},{"key":"10782_CR34","doi-asserted-by":"publisher","first-page":"691","DOI":"10.2169\/internalmedicine.32.691","volume":"32","author":"M Saitoh","year":"1993","unstructured":"Saitoh M, Miyakoda H, Kitamura H, Allen AM, May CN (1993) Effects of an angiotensin-converting enzyme inhibitor, alacepril, on cardiovascular and sympathetic nervous responses to mental stress in patients with essential hypertension. Intern Med 32:691\u2013694. https:\/\/doi.org\/10.2169\/internalmedicine.32.691","journal-title":"Intern Med"},{"key":"10782_CR35","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.jvc.2016.05.001","volume":"18","author":"A Sakatani","year":"2016","unstructured":"Sakatani A, Miyagawa Y, Takemura N (2016) Evaluation of the effect of an angiotensin-converting enzyme inhibitor, alacepril, on drug-induced renin-angiotensin-aldosterone system activation in normal dogs. J Vet Cardiol 18:248\u2013254. https:\/\/doi.org\/10.1016\/j.jvc.2016.05.001","journal-title":"J Vet Cardiol"},{"key":"10782_CR36","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/00140137308924479","volume":"16","author":"BM Sayers","year":"1973","unstructured":"Sayers BM (1973) Analysis of heart rate variability. Ergonomics 16:17\u201332. https:\/\/doi.org\/10.1080\/00140137308924479","journal-title":"Ergonomics"},{"key":"10782_CR37","doi-asserted-by":"publisher","first-page":"3300","DOI":"10.1038\/s41598-023-30453-x","volume":"13","author":"BK Schneider","year":"2023","unstructured":"Schneider BK, Ward J, Sotillo S et al (2023) Breakthrough: a first-in-class virtual simulator for dose optimization of ACE inhibitors in translational cardiovascular medicine. Sci Rep 13:3300. https:\/\/doi.org\/10.1038\/s41598-023-30453-x","journal-title":"Sci Rep"},{"key":"10782_CR38","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1056\/NEJM199908193410806","volume":"341","author":"RW Schrier","year":"1999","unstructured":"Schrier RW, Abraham WT (1999) Hormones and hemodynamics in heart failure. N Engl J Med 341:577\u2013585. https:\/\/doi.org\/10.1056\/NEJM199908193410806","journal-title":"N Engl J Med"},{"key":"10782_CR39","doi-asserted-by":"publisher","first-page":"12305","DOI":"10.3390\/ijms222212305","volume":"22","author":"J Shanks","year":"2021","unstructured":"Shanks J, Ramchandra R (2021) Angiotensin II and the cardiac parasympathetic nervous system in hypertension. Int J Mol Sci 22:12305. https:\/\/doi.org\/10.3390\/ijms222212305","journal-title":"Int J Mol Sci"},{"key":"10782_CR40","doi-asserted-by":"publisher","first-page":"1078","DOI":"10.3390\/ani14071078","volume":"14","author":"K Shimada","year":"2024","unstructured":"Shimada K, Hirose M, Hamabe L et al (2024) Evaluation of alacepril administration in canine patent ductus arteriosus according to plasma chymase activity. Anim (Basel) 14:1078. https:\/\/doi.org\/10.3390\/ani14071078","journal-title":"Anim (Basel)"},{"key":"10782_CR41","doi-asserted-by":"publisher","first-page":"2684","DOI":"10.1038\/s41598-023-29771-x","volume":"13","author":"S Sotillo","year":"2023","unstructured":"Sotillo S, Ward JL, Guillot E et al (2023) Dose-response of benazepril on biomarkers of the classical and alternative pathways of the renin-angiotensin-aldosterone system in dogs. Sci Rep 13:2684. https:\/\/doi.org\/10.1038\/s41598-023-29771-x","journal-title":"Sci Rep"},{"key":"10782_CR42","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1002\/j.1552-4604.1992.tb05779.x","volume":"32","author":"T Sumimoto","year":"1992","unstructured":"Sumimoto T, Ochi T, Hiwada K (1992) Effects of a long-term treatment with alacepril on left ventricular hypertrophy and function in patients with essential hypertension. J Clin Pharmacol 32:667\u2013670. https:\/\/doi.org\/10.1002\/j.1552-4604.1992.tb05779.x","journal-title":"J Clin Pharmacol"},{"key":"10782_CR43","first-page":"74","volume":"36","author":"K Takeyama","year":"1986","unstructured":"Takeyama K, Minato H, Ikeno A, Hosoki K, Kadokawa T (1986) Antihypertensive mechanism of alacepril: effect on norepinephrine-induced vasoconstrictive response in vitro and in vivo. Arzneimittelforschung 36:74\u201377","journal-title":"Arzneimittelforschung"},{"key":"10782_CR44","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1292\/jvms.64.1023","volume":"64","author":"M Uechi","year":"2002","unstructured":"Uechi M, Shimizu A, Mizuno M (2002) Heart rate modulation by sympathetic nerves in dogs with heart failure. J Vet Med Sci 64:1023\u20131029. https:\/\/doi.org\/10.1292\/jvms.64.1023","journal-title":"J Vet Med Sci"},{"key":"10782_CR45","doi-asserted-by":"publisher","first-page":"29","DOI":"10.56808\/2985-1130.2886","volume":"48","author":"A Uemura","year":"2018","unstructured":"Uemura A, Hamabe L, Shimada K et al (2018) Evaluation of symptomatic improvements observed by switching to alacepril from other ACE-inhibitors in dogs with mitral valve regurgitation. Wetchasan Sattawaphaet 48:29\u201336. https:\/\/doi.org\/10.56808\/2985-1130.2886","journal-title":"Wetchasan Sattawaphaet"},{"key":"10782_CR46","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/sj.bjp.0705262","volume":"139","author":"SJ Veerasingham","year":"2003","unstructured":"Veerasingham SJ, Raizada MK (2003) Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives: brain renin-angiotensin system in hypertension. Br J Pharmacol 139:191\u2013202. https:\/\/doi.org\/10.1038\/sj.bjp.0705262","journal-title":"Br J Pharmacol"},{"key":"10782_CR47","doi-asserted-by":"publisher","unstructured":"Weber KT (2001) Aldosterone in congestive heart failure. N Engl J Med 345:1689\u20131697. https:\/\/doi.org\/10.1056\/NEJMra000050","DOI":"10.1056\/NEJMra000050"},{"key":"10782_CR48","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1111\/j.1939-1676.1995.tb01075.x","volume":"9","author":"JA Woodfield","year":"1995","unstructured":"Woodfield JA (1995) Controlled clinical evaluation of enalapril in dogs with heart failure: results of the cooperative veterinary enalapril study group. The COVE study group. J Vet Intern Med 9:243\u2013252. https:\/\/doi.org\/10.1111\/j.1939-1676.1995.tb01075.x","journal-title":"J Vet Intern Med"},{"key":"10782_CR49","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1111\/j.1939-1676.1995.tb01074.x","volume":"9","author":"J Woodfield","year":"1995","unstructured":"Woodfield J, Bauer T, Rush J et al (1995) Acute and short-term hemodynamic, echocardiographic, and clinical effects of enalapril maleate in dogs with naturally acquired heart failure: results of the invasive multicenter prospective veterinary evaluation of enalapril study. the IMPROVE study group. J Vet Intern Med 9:234\u2013242. https:\/\/doi.org\/10.1111\/j.1939-1676.1995.tb01074.x","journal-title":"J Vet Intern Med"},{"key":"10782_CR50","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1254\/jphs.12283fp","volume":"122","author":"F Yamaki","year":"2013","unstructured":"Yamaki F, Arai T, Aoyama M, Watanabe A, Takata Y (2013) Angiotensin AT(1)-receptor blockers enhance cardiac responses to parasympathetic nerve stimulation via presynaptic AT(1) receptors in pithed rats. J Pharmacol Sci 122:28\u201333. https:\/\/doi.org\/10.1254\/jphs.12283fp","journal-title":"J Pharmacol Sci"},{"key":"10782_CR51","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1161\/01.hyp.0000018590.26853.c7","volume":"39","author":"S Ye","year":"2002","unstructured":"Ye S, Zhong H, Duong VN, Campese VM (2002) Losartan reduces central and peripheral sympathetic nerve activity in a rat model of neurogenic hypertension. Hypertension 39:1101\u20131106. https:\/\/doi.org\/10.1161\/01.hyp.0000018590.26853.c7","journal-title":"Hypertension"},{"key":"10782_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1536\/ihj.36.91","volume":"36","author":"T Yoshikawa","year":"1995","unstructured":"Yoshikawa T, Handa S, Nagami K et al (1995) Effect of the angiotensin-converting enzyme inhibitor alacepril on ventricular function and beta-adrenoceptor number in rabbits with aortic regurgitation. Jpn Heart J 36:91\u2013100. https:\/\/doi.org\/10.1536\/ihj.36.91","journal-title":"Jpn Heart J"},{"key":"10782_CR53","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/hrt.72.6.528","volume":"72","author":"M Yoshimura","year":"1994","unstructured":"Yoshimura M, Yasue H, Tanaka H et al (1994) Responses of plasma concentrations of A type natriuretic peptide and B type natriuretic peptide to Alacepril, an angiotensin-converting enzyme inhibitor, in patients with congestive heart failure. Br Heart J 72:528\u2013533. https:\/\/doi.org\/10.1136\/hrt.72.6.528","journal-title":"Br Heart J"}],"container-title":["Veterinary Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-025-10782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11259-025-10782-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11259-025-10782-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T17:06:31Z","timestamp":1757178391000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11259-025-10782-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,3]]},"references-count":53,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["10782"],"URL":"https:\/\/doi.org\/10.1007\/s11259-025-10782-0","relation":{},"ISSN":["0165-7380","1573-7446"],"issn-type":[{"type":"print","value":"0165-7380"},{"type":"electronic","value":"1573-7446"}],"subject":[],"published":{"date-parts":[[2025,6,3]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures and experimental conditions adhered to the Guide for the Care and Use of Laboratory Animals, and the experiments were approved by the Experimental Animal Committee of Nihon University (approval no. AP22BRS013-1).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"212"}}